CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope
- 10 March 2006
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 24 (11), 1880-1888
- https://doi.org/10.1016/j.vaccine.2005.10.036
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- IPC: Professional Type 1 Interferon-Producing Cells and Plasmacytoid Dendritic Cell PrecursorsAnnual Review of Immunology, 2005
- Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell MemoryScience, 2003
- Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic CellsThe Journal of Experimental Medicine, 2002
- Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12European Journal of Immunology, 2001
- H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesEuropean Journal of Immunology, 1999
- SELECTION OF THE T CELL REPERTOIREAnnual Review of Immunology, 1999
- The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-LigandThe Journal of Experimental Medicine, 1997
- Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T-cell help in CD8+ T-cell responsesCurrent Biology, 1994
- Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4Nature, 1991
- Three‐cell‐type clusters of T cells with antigen‐presenting cells best explain the epitope linkage and noncognate requirements of the in vivo cytolytic responseEuropean Journal of Immunology, 1987